Melinta Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MLNT and buy or sell other stocks, ETFs, and their options commission-free!About MLNT
Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections.
CEOChristine Ann Miller, MBA
CEOChristine Ann Miller, MBA
Employees—
Employees—
HeadquartersParsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded2000
Founded2000
Employees—
Employees—
MLNT Key Statistics
Market cap1.51M
Market cap1.51M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume71.61K
Average volume71.61K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.60
52 Week high$8.60
52 Week low$0.06
52 Week low$0.06
Stock Snapshot
As of today, Melinta Therapeutics(MLNT) shares are valued at $0.15. The company's market cap stands at 1.51M.
During the trading day, Melinta Therapeutics(MLNT) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 71.61K.
The stock's 52-week range extends from a low of $0.06 to a high of $8.60.
The stock's 52-week range extends from a low of $0.06 to a high of $8.60.